Health
Selecting SARS-CoV-2 inhibitors in human airway epithelial cells – News-Medical.Net
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe…
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The vaccination campaign is our current answer against the ongoing spread of SARS-CoV-2 and coronavirus disease (COVID-19) pandemic….
-
Noosa News22 hours agoBali traveller sparks urgent measles alert across Queensland
-
Noosa News21 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business24 hours agoEverything you need to know about the Coles dividend
-
Business22 hours agoThe best ASX ETFs for compounding wealth until 2040